- Under Armour warns of worsening impact on Middle East market, lowers annual gross margin growth target
- Lifetime Brands clarifies trailing 12-month adjusted EBITDA before limitations is $92.4 million
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- SUN LIFE FINANCIAL INC <SLF.TO>: RBC CUTS TARGET PRICE TO C$108 FROM C$119
- Indian Stocks Defy Asian Sell-Off as Nifty Hits Three-Month High
- TRISURA GROUP LTD. <TSU.TO>: RAYMOND JAMES CUTS TARGET PRICE TO C$52 FROM C$57.5
- FactSet Declares Quarterly Cash Dividend of $1.16 Per Share
- Grendene Announces Dividend of R$ 0.060000913 per Share
- VAALCO Energy forecasts 2026 capital spending of $300 million-$330 million
- Mitsubishi UFJ: AI Stock Sell-off May Weaken the Pound Sterling
- JFROG LTD. <FROG.O>: TD COWEN RAISES TARGET PRICE TO $135 FROM $120
- EVERCOMMERCE, INC. <EVCM.O>: OPPENHEIMER CUTS TARGET PRICE TO $11 FROM $13
- EVOLENT HEALTH <EVH.N>: OPPENHEIMER RAISES TARGET PRICE TO $7 FROM $6
- ORMAT TECHNOLOGIES, INC. <ORA.N>: OPPENHEIMER CUTS TARGET PRICE TO $130 FROM $145
- PALVELLA THERAPEUTICS INC. : OPPENHEIMER RAISES TARGET PRICE TO $232 FROM $210
- SWEETGREEN, INC. <SG.N>: OPPENHEIMER RAISES TARGET PRICE TO $14 FROM $8.5
- UNITY SOFTWARE INC. <U.N>: OPPENHEIMER RAISES TARGET PRICE TO $64 FROM $47
- ARTERIS, INC. : OPPENHEIMER CUTS TARGET PRICE TO $30 FROM $40
- ADVANCED DRAINAGE SYSTEMS <WMS.N>: OPPENHEIMER CUTS TARGET PRICE TO $180 FROM $185
- AIRBNB INC. : OPPENHEIMER RAISES TARGET PRICE TO $230 FROM $210
- AMERICAN SUPERCONDUCTOR : OPPENHEIMER CUTS TARGET PRICE TO $52 FROM $71
- BENTLEY SYSTEMS <BSY.O>: OPPENHEIMER RAISES TARGET PRICE TO $52 FROM $43
- Arbitrage Holdings Remains in Advanced Funding Talks for Coal Mining Assets
- IONQ, INC. <IONQ.N>: NORTHLAND CAPITAL CUTS TARGET PRICE TO $63 FROM $70
- Bischoff Family Reports 29.90% Voting Rights in Deutz
- Garanti Finansal Kiralama Secures Parent’s Commitment to TRY 17 Billion Capital Increase
- Mineralys Therapeutics Grants New Employee 14,880 Stock Options, 11,160 Restricted Stock Units
- KeyCorp Publishes Update to Financial Calendar
- Protara Therapeutics 3Q Research and Development Expenses $16.8M >TARA
- BetterLife Pharma Seeks Shareholder Approval of Advance Notice Policy for Director Nominations
- Integra LifeSciences to Present at UBS Global Healthcare Conference
- Aurelion Forms Digital Asset Management Committee
- Protara Therapeutics Q3 2026 net loss widens 64% to $21.69 million
- WSP GLOBAL INC <WSP.TO>: ATB CORMARK CAPITAL MARKETS CUTS TARGET PRICE TO C$315 FROM C$325
- DarkHorse Q3 2026 net loss widens 36% year over year to USD 5.78 million
- Aligos Therapeutics 3Q Loss $21.9M >ALGS
- SCI Board Member Oliver Wiederhold Receives Tender Rights for 26,050 Shares Worth EUR 534,025
- TENAZ ENERGY CORP. <TNZ.TO>: ATB CORMARK CAPITAL MARKETS CUTS TARGET PRICE TO C$80 FROM C$90
- Dauch swings to Q3 2026 net loss of $45.3 million
- Strive swings to Q3 net income of $509.03 million
- First Bancorp's First Bank opens SouthPark branch and office in Charlotte
- US PHYSICAL THERAPY INC <USPH.N>: BARRINGTON RESEARCH RAISES TARGET PRICE TO $110 FROM $98
- BitFuFu October Bitcoin Production Falls to 137 BTC From 167 BTC in September
- Acrivon Acquires JAK1 Inhibitor ACR-525, Preclinical Program From Aqilion
- Bending Spoons publishes update to financial calendar
- Ametek Declares Quarterly Dividend of $0.34 Per Share
- Desert Control Announces Investor Call for Business and Financial Update
- Goldhills Plans to Fund Lennac Lake Copper-Molybdenum Exploration With Placement Proceeds
- Teledyne Participates in Baird Global Industrial Conference
- Andreas F. J. Obereder's ATOSS Voting Rights Remain Unchanged at 25.08%
- Strive 3Q EPS $5.24 >ASST
- Dauch Cuts 2026 Adjusted Ebitda View to $1.35B-$1.375B From $1.36B-$1.425B >DCH
- Ascendis Pharma Plans YUVIWEL Launch in Germany in Q1 2027, Pending EU Approval
- MiMedx Participates in Canaccord and Craig-Hallum Investor Conferences
- Pulse Oil plans Bigoray well restart to boost production
- TC ENERGY CORPORATION <TRP.TO>: ATB CORMARK CAPITAL MARKETS RAISES OUTPERFORM FROM SECTOR PERFORM
- Global Partners Q3 2026 net income jumps 80% to $52.36 million
- AAON Participates in Baird Global Industrial Conference
- Sabine Royalty Trust Raises November Cash Distribution to $0.360390 Per Unit
- REV Exploration Begins Completion Operations at Aden Dome Helium Discovery
- Taysha Gene Therapies Grants Two New Employees RSUs Covering 25,000 Shares
- Decibel publishes update to financial calendar
- enGene to Participate in UBS and Jefferies Investor Conferences
- Fynske Bank to Pay No Dividend for 2026
- NORTH AMERICAN CONSTRUCTION GROUP LTD <NOA.TO>: ATB CORMARK CAPITAL MARKETS CUTS TARGET PRICE TO C$17.5 FROM C$23.5
- Gilt Yields Rise Ahead of U.S. Jobs Data -- Market Talk
- Dauch Raises 2026 View To Sales $10.8B-$10.875B >DCH
- Dauch Had Seen 2026 Sales $10.6B-$10.8B >DCH
- Rogers Communications Publishes Q3 2026 Results Conference Call Transcript
- Enhanced Group Publishes Update to Financial Calendar
- Thungela Company Secretary Tovi Ellis Sells R 139,105.96 in Shares to Settle Tax Obligations
- Global Partners 3Q Sales $6.68B >GLP
- Marcus & Millichap 3Q Net $1.01M >MMI
- Marcus & Millichap 3Q EPS 3c >MMI
- Protara Therapeutics 3Q Loss $21.7M >TARA
- Aligos Therapeutics 3Q Loss/Shr $2.09 >ALGS
- Global Partners 3Q Net $52.4M >GLP
- EDP Renewables Publishes Transcript of Nine-Month 2026 Results Call
- Koppers Cuts 2026 View To Adj EPS $3.10-Adj EPS $3.25 >KOP
- Koppers Sees 2026 Sales $1.9B >KOP
- Plains All American Pipeline Swings to Q3 Adjusted Loss, Revenue Increases
- --GUIDANCE: (DCH) Dauch Expects 2026 Sales Range $10.8B - $10.88B, vs. FactSet Est of $10.70B
- Array Digital Infrastructure Q3 Swings to Profit as Revenue Rises
- --GUIDANCE: (EHC) Encompass Health Expects 2026 Operating Revenue Range $6.45B - $6.50B, vs. FactSet Est of $6.47B
- --GUIDANCE: (EHC) Encompass Health Expects 2026 Adjusted EPS Range $6.23 - $6.37, vs. FactSet Est of $6.28
- MSG Knickerbockers Fiscal Q1 Loss Widens, Revenue Rises
- --GUIDANCE: (KOP) Koppers Expects 2026 Net Sales $1.9B, vs. FactSet Est of $1.94B
- RBC Raises Price Target on ACADIA Pharmaceuticals to $41 From $31, Keeps Outperform Rating
- --B. Riley Adjusts Applied Optoelectronics Price Target to $45 From $92, Maintains Neutral Rating
- -- Earnings Flash (DCH) Dauch Corporation Posts Q3 Adjusted EPS $0.22 per Share, vs. FactSet Est of $0.16
- -- Earnings Flash (DCH) Dauch Corporation Reports Q3 Revenue $2.91B, vs. FactSet Est of $2.76B
- Oklo, US Forged Rings Sign Deal for Aurora Reactor Components
- --Earnings Flash (GLP) Global Partners Posts Q3 Net Income $1.26 per Unit, vs. FactSet Est of $1.61
- -- Earnings Flash (GLP) Global Partners LP Reports Q3 Revenue $6.68B, vs. FactSet Est of $7.41B
- --GUIDANCE: (KOP) Koppers Expects 2026 Adjusted EPS Range $3.10 - $3.25, vs. FactSet Est of $4.03
- -- Earnings Flash (ASST) Strive, Inc. Reports Q3 Revenue $2.7M, vs. FactSet Est of $3.0M
- -- Earnings Flash (ASST) Strive, Inc. Posts Q3 Adjusted EPS $5.46 per Share
- --Earnings Flash (KOP) Koppers Posts Q3 Adjusted EPS $0.77, vs. FactSet Est of $1.37
